RQR invests in early stage life science companies based on a strict investment profile model. Considerations include:
- Commercial Viability Assessment
- Potential Strategic Partners
- 3 to 5 year time horizon for a return on investment through a liquidity event
In addition to offering funding services for early stage life science companies that meet the RQR model, we prepare our clients to have fruitful investor meetings.
RQR also advises entrepreneurs on potential sources of non-dilutive funding from a variety of US federal agencies. These resources have been used to bring products to market through our commercial technology partners.